Maa: Yhdistynyt kuningaskunta
Kieli: englanti
Lähde: MHRA (Medicines & Healthcare Products Regulatory Agency)
Liquid paraffin; White soft paraffin; Emulsifying wax
Actavis UK Ltd
n/a
Liquid paraffin; White soft paraffin; Emulsifying wax
200mg/1gram ; 500mg/1gram ; 300mg/1gram
Cutaneous ointment
Cutaneous
No Controlled Drug Status
Valid as a prescribable product
BNF: 13020100
keyline text free area 164.363 mm 39.81 mm 159.407 mm Braille Translation: EMULSIFYING OINTMENT BP EMULSIFYING OINTMENT BP EMULSIFYING OINTMENT BP Lue koko asiakirja
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Emulsifying Ointment BP. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Emulsifying Wax 30% White Soft Paraffin 50% Liquid Paraffin 20% Wax as prepared in section 6.1 3. PHARMACEUTICAL FORM Ointment 4. CLINICAL PARTICULARS 4.1. THERAPEUTIC INDICATIONS For external use only. Used to prepare Aqueous Cream BP and Buffered Cream BP. 4.2. POSOLOGY AND METHOD OF ADMINISTRATION The product is used by the pharmacist to prepare Aqueous Cream and Buffered Cream and therefore is not sold with any clinical indications or dosage schedules. 4.3. CONTRAINDICATIONS Hypersensitivity to any of the ingredients. Emulsifying ointment has been found to have major sunscreen activity in clinically normal skin. Preparations containing emulsifying ointment should not be used before phototherapy or in phototesting procedures. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE For external use only. Emulsifying wax (which contains sodium lauryl sulphate and cetostearyl alcohol) may cause local skin reactions (e.g. stinging, burning, itching, redness and contact dermatitis), particularly in children with atopic eczema. The package leaflet/label should include the following information: Contains sodium lauryl sulfate which may cause local skin reactions (e.g. stinging and contact dermatitis). The risk of fire should be considered when using large quantities of any paraffin-based emollient. Emulsifying ointment in contact with dressings and clothing is easily ignited by a naked flame. The risk is greater when this preparation is applied to large areas of the body and clothing or dressings become soaked with the emollient. Patients should be told to keep away from fire or flames and not to smoke when using this preparation. This preparation may make skin and surfaces slippery – particular care is needed when bathing. Instruct patients not to smoke or go near naked flames - risk of severe burns. Fabric (clothing, bedding, dressings etc) that has been in contact with this product burns mo Lue koko asiakirja